𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Claims on tissue plasminogen activator

✍ Scribed by Crespi, R. Stephen


Book ID
109757729
Publisher
Nature Publishing Group
Year
1989
Tongue
English
Weight
258 KB
Volume
337
Category
Article
ISSN
0028-0836

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Tissue Activator of Plasminogen
✍ LACK, CHARLES H.; YOUSUF ALI, S. πŸ“‚ Article πŸ“… 1964 πŸ› Nature Publishing Group 🌐 English βš– 266 KB
Effect of oral defibrotide on tissue-pla
✍ F. Violi; D. Ferro; M. Saliola; C. Quintarelli; S. Basili; F. Balsano πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 491 KB

Defibrotide, a polydeoxyribonucleotide of mammalian origin, has been shown to reduce the blood level of the plasminogen activator inhibitor, and so to increase the activity of tissue plasminogen activator without any adverse effect. A randomized, double-blind, placebo-controlled study has been done

Tissue Plasminogen Activator in Psoriasi
✍ Jensen, Pamela J.; Baird, Janet; Belin, Dominique; Vassalli, Jean-Dominique; Bus πŸ“‚ Article πŸ“… 1990 πŸ› Nature Publishing Group 🌐 English βš– 431 KB
Tissue plasminogen activator and glial f
✍ Iordanis Gravanis; Stella E. Tsirka πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

## Abstract Tissue plasminogen activator (tPA) is the only FDA‐approved treatment of thrombotic stroke and is a major parenchymal serine protease in the brain. However, it has been implicated in a plethora of brain pathologies, raising concern about its use as a safe therapeutic. tPA is thought to